Vicente J. Anido
Director/Board Member chez B+L Diagnostics, Inc.
Profil
Vicente J.
Anido is currently a Director at The West Virginia University Foundation, Inc., BIOCOM, and B+L Diagnostics, Inc. He previously served as President & Chief Executive Officer at CombiChem, Inc., President, Chief Executive Officer & Director at ISTA Pharmaceuticals, Inc., Chairman & Chief Executive Officer at Aerie Pharmaceuticals, Inc., and held various director positions at Apria Healthcare Group LLC, QLT, Inc., Assertio Therapeutics, Inc., and Nicox SA. He was also the President-American Region at Allergan, Inc. and Vice President-Business Management at Marion Merrell Dow, Inc. He was a General Partner at Windamere Venture Partners LLC.
He received his undergraduate and graduate degrees from West Virginia University and his doctorate from the University of Missouri-Kansas City.
Postes actifs de Vicente J. Anido
Sociétés | Poste | Début |
---|---|---|
B+L Diagnostics, Inc.
B+L Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bausch Health Cos., Inc., B+L Diagnostics, Inc. is a private company that manufactures and distributes biopharmaceuticals. The company is based in Warren Township, NJ. B+L Diagnostics was acquired by Bausch Health Cos., Inc. from Nicox SA on November 17, 2014 for $20 million. | Director/Board Member | - |
The West Virginia University Foundation, Inc.
The West Virginia University Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The West Virginia University Foundation, Inc. provides financial support to charitable causes. The company's services include fund raising and management of the assets of West Virginia University. It seeks support for faculty, programs, services, equipment, and facilities. The company was founded in 1954 and is headquartered in Morgantown, WV. | Director/Board Member | - |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Director/Board Member | - |
Anciens postes connus de Vicente J. Anido
Sociétés | Poste | Fin |
---|---|---|
AERIE PHARMACEUTICALS, INC. | Chief Executive Officer | 17/09/2021 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Director/Board Member | 18/05/2016 |
NICOX SA | Director/Board Member | 11/08/2014 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Director/Board Member | 09/11/2013 |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Chief Executive Officer | 31/12/2012 |
Formation de Vicente J. Anido
West Virginia University | Graduate Degree |
University of Missouri-Kansas City | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
NICOX SA | Health Technology |
Entreprise privées | 13 |
---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Apria Healthcare Group LLC
Apria Healthcare Group LLC Medical/Nursing ServicesHealth Services Apria Healthcare Group, Inc. engages in the provision of home healthcare products and services. It services include therapies, clinical programs, and home medical equipment. The company was founded in 1924 and is headquartered in Lake Forest, CA. | Health Services |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
CombiChem, Inc.
CombiChem, Inc. Miscellaneous Commercial ServicesCommercial Services CombiChem, Inc. used to provide computational drug recovery services to accelerate the discovery process for new drugs and chemical compounds. The company was founded in 1994 and headquartered in San Diego, CA | Commercial Services |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Health Technology |
Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
Marion Merrell Dow, Inc. | Health Technology |
The West Virginia University Foundation, Inc.
The West Virginia University Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The West Virginia University Foundation, Inc. provides financial support to charitable causes. The company's services include fund raising and management of the assets of West Virginia University. It seeks support for faculty, programs, services, equipment, and facilities. The company was founded in 1954 and is headquartered in Morgantown, WV. | Commercial Services |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Commercial Services |
Windamere Venture Partners LLC
Windamere Venture Partners LLC Investment ManagersFinance Windamere Venture Partners LLC (Windamere Venture Partners) is an independent venture capital firm founded in 1999 by Scott L. Glenn. The firm is headquartered in San Diego. | Finance |
Marion Laboratories | Distribution Services |
B+L Diagnostics, Inc.
B+L Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bausch Health Cos., Inc., B+L Diagnostics, Inc. is a private company that manufactures and distributes biopharmaceuticals. The company is based in Warren Township, NJ. B+L Diagnostics was acquired by Bausch Health Cos., Inc. from Nicox SA on November 17, 2014 for $20 million. | Health Technology |